D.A. Davidson & Co’s BioNTech BNTX Stock Holding History

D.A. Davidson & Co’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,330	Closed	-$347K	–	1293
2022 Q2	$347K	Sell	2,330 -736	-24%	-$112K	﹤0.01%	952
2022 Q1	$523K	Buy	+3,066	New	+$515K	0.01%	866

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

D.A. Davidson & Co's BNTX Position: Q3 2022 in Review

D.A. Davidson & Co sold out of BioNTech (BNTX) in Q3 2022, closing a stake of 2,330 shares — an estimated $347K sold.

D.A. Davidson & Co first reported a position in BNTX in Q1 2022 and held it in 2 quarters. The position peaked at $523K in Q1 2022. 264 funds tracked by Wall St. Rank hold BNTX as of Q3 2022.

D.A. Davidson & Co reported no remaining BioNTech position as of Q3 2022 after selling out during the quarter.
D.A. Davidson & Co sold 2,330 BioNTech shares in Q3 2022, an estimated $347K.
D.A. Davidson & Co first reported a position in BioNTech in Q1 2022 and held it in 2 quarters.
D.A. Davidson & Co's BioNTech position peaked at $523K in Q1 2022.
264 funds tracked by Wall St. Rank held BioNTech as of Q3 2022.

Based on D.A. Davidson & Co's 13F filing for Q3 2022, filed 7 Nov 2022.